Vor to participate in two upcoming investor conferences

Cambridge, mass., nov. 08, 2021 (globe newswire) -- vor biopharma (nasdaq: vor), a cell and genome engineering company, today announced that robert ang, m.b.b.s., mba, vor's president and chief executive officer, and nathan jorgensen, ph.d., vor's chief financial officer, will be participating in two upcoming virtual investor conferences:

VOR Ratings Summary

VOR Quant Ranking